epirubicin has been researched along with Myasthenia Gravis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambrogi, MC; Angeletti, CA; Basolo, F; Duranti, L; Fontanini, G; Lucchi, M; Mussi, A | 1 |
1 other study(ies) available for epirubicin and Myasthenia Gravis
Article | Year |
---|---|
Advanced stage thymomas and thymic carcinomas: results of multimodality treatments.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Neoadjuvant Therapy; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Thymoma; Thymus Neoplasms; Treatment Outcome | 2005 |